PACEMAKERS (Continued) 2002 Cardiovascular Conference Report Recommendation Tables, Page 102 PHYSIOLOGY/ DIAGNOSIS CERTIFICATION RE-CERTIFICATION FUNCTIONAL Neurocardiogenic Excellent long-term No, with symptoms. Syncope survival prognosis but there is risk for syncope Yes if: Annual that may be due to 3 months* after Documented pacemaker cardioinhibitory (slowing pacemaker implantation; checks; heart rate) or Documented correct Absence of symptom vasodepressor (drop in function by pacemaker recurrence blood pressure) center; Absence of components, or both. symptom recurrence. Pacemaker will affect only cardioinhibitory component, but will lessen effect of vasodepressor component. *Three months recommended due to possible vasodepressor component of syndrome not necessarily treated by pacing.
PACEMAKERS (Continued) 2002 Cardiovascular Conference Report Recommendation Tables, Page 102 DIAGNOSIS PHYSIOLOGY/ FUNCTIONAL CERTIFICATION RE-CERTIFICATION Neurocardiogenic Syncope Excellent long-term survival prognosis but there is risk for syncope that may be due to cardioinhibitory (slowing heart rate) or vasodepressor (drop in blood pressure) components, or both. Pacemaker will affect only cardioinhibitory component, but will lessen effect of vasodepressor component. No, with symptoms. Yes if: 3 months* after pacemaker implantation; Documented correct function by pacemaker center; Absence of symptom recurrence. Annual Documented pacemaker checks; Absence of symptom recurrence *Three months recommended due to possible vasodepressor component of syndrome not necessarily treated by pacing.
proposed-changes-medical-examiners-handbook.docx